IUGNF
Price
$0.03
Change
+$0.01 (+50.00%)
Updated
Jan 17 closing price
Capitalization
187.98M
OMGA
Price
$0.55
Change
-$0.02 (-3.51%)
Updated
Jan 17 closing price
Capitalization
30.4M
46 days until earnings call
Ad is loading...

IUGNF vs OMGA

Header iconIUGNF vs OMGA Comparison
Open Charts IUGNF vs OMGABanner chart's image
Imugene
Price$0.03
Change+$0.01 (+50.00%)
Volume$189.29K
Capitalization187.98M
Omega Therapeutics
Price$0.55
Change-$0.02 (-3.51%)
Volume$204.84K
Capitalization30.4M
IUGNF vs OMGA Comparison Chart
Loading...
IUGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IUGNF vs. OMGA commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IUGNF is a Hold and OMGA is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (IUGNF: $0.03 vs. OMGA: $0.55)
Brand notoriety: IUGNF and OMGA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IUGNF: 117% vs. OMGA: 67%
Market capitalization -- IUGNF: $187.98M vs. OMGA: $30.4M
IUGNF [@Biotechnology] is valued at $187.98M. OMGA’s [@Biotechnology] market capitalization is $30.4M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IUGNF’s FA Score shows that 0 FA rating(s) are green whileOMGA’s FA Score has 0 green FA rating(s).

  • IUGNF’s FA Score: 0 green, 5 red.
  • OMGA’s FA Score: 0 green, 5 red.
According to our system of comparison, both IUGNF and OMGA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IUGNF’s TA Score shows that 4 TA indicator(s) are bullish while OMGA’s TA Score has 3 bullish TA indicator(s).

  • IUGNF’s TA Score: 4 bullish, 4 bearish.
  • OMGA’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, OMGA is a better buy in the short-term than IUGNF.

Price Growth

IUGNF (@Biotechnology) experienced а -12.41% price change this week, while OMGA (@Biotechnology) price change was -22.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

OMGA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IUGNF($188M) has a higher market cap than OMGA($30.4M). IUGNF YTD gains are higher at: 18.140 vs. OMGA (-26.368).
IUGNFOMGAIUGNF / OMGA
Capitalization188M30.4M618%
EBITDAN/A-66.84M-
Gain YTD18.140-26.368-69%
P/E RatioN/AN/A-
RevenueN/A8.1M-
Total CashN/A30.4M-
Total DebtN/A128M-
TECHNICAL ANALYSIS
Technical Analysis
IUGNFOMGA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
88%
Momentum
ODDS (%)
Bullish Trend 11 days ago
88%
Bearish Trend 11 days ago
89%
MACD
ODDS (%)
Bullish Trend 11 days ago
90%
Bullish Trend 11 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 27 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
IUGNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMGA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAB0.490.01
+1.46%
BioAtla
MSGS217.001.80
+0.84%
Madison Square Garden Sports Corp
DDL3.370.02
+0.60%
Dingdong (Cayman) Limited
ADM51.290.28
+0.55%
Archer Daniels Midland Company
EIG49.81-0.42
-0.84%
Employers Holdings

IUGNF and

Correlation & Price change

A.I.dvisor tells us that IUGNF and DRUG have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IUGNF and DRUG's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IUGNF
1D Price
Change %
IUGNF100%
+2.01%
DRUG - IUGNF
21%
Poorly correlated
+0.49%
OMGA - IUGNF
21%
Poorly correlated
-3.04%
OTLC - IUGNF
13%
Poorly correlated
-20.98%
INRLF - IUGNF
8%
Poorly correlated
N/A
KNBIF - IUGNF
7%
Poorly correlated
-3.07%
More